PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. [electronic resource]
Producer: 20210316ISSN:- 2073-4409
- Adult
- Aged
- Apoptosis -- drug effects
- Biomarkers, Pharmacological
- Biomarkers, Tumor
- Biphenyl Compounds -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Colorectal Neoplasms -- drug therapy
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Plasminogen Activator Inhibitor 1 -- metabolism
- Prognosis
- Protein Kinase Inhibitors
- Protein Serine-Threonine Kinases -- metabolism
- Rectal Neoplasms -- drug therapy
- Thiazolidines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.